63.0 percent of patients reached full remission at day three; remission remained high at 69.5 percent at week six
THURSDAY, Feb. 3, 2022 (HealthDay News) — For patients hospitalized with current suicidal ideation, ketamine is effective and safe in the short term, according to a study published online Feb. 2 in The BMJ.
Mocrane Abbar, M.D., from the University of Montpellier in Nîmes, France, and colleagues conducted a prospective trial between April 13, 2015, and March 12, 2019, involving 156 adults with current suicidal ideation admitted to the hospital voluntarily. Participants were randomly assigned to either placebo or ketamine (83 and 73, respectively), stratified by center and diagnosis.
The researchers found that compared with those receiving placebo, more participants receiving ketamine reached full remission of suicidal ideation at day three (63.0 versus 31.6 percent; odds ratio, 3.7; 95 percent confidence interval, 1.9 to 7.3; P
“Whether the emergency use of ketamine for suicidal crises will be recommended in practice depends on many other factors, including the values and preferences of patients, clinicians, researchers, and policymakers,” write the authors of an accompanying editorial.
Several authors disclosed financial ties to the pharmaceutical industry.
Copyright © 2021 HealthDay. All rights reserved.